Tibra Equities Europe’s Milestone Scientific MLSS Stock Holding History

Tibra Equities Europe’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-163,800	Closed	-$401K	–	135
2021 Q2	$401K	Buy	+163,800	New	+$397K	0.12%	33

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Tibra Equities Europe's MLSS Position: Q3 2021 in Review

Tibra Equities Europe sold out of Milestone Scientific (MLSS) in Q3 2021, closing a stake of 163,800 shares — an estimated $401K sold.

Tibra Equities Europe first reported a position in MLSS in Q2 2021 and held it in 1 quarter. The position peaked at $401K in Q2 2021. 37 funds tracked by Wall St. Rank hold MLSS as of Q3 2021.

Tibra Equities Europe reported no remaining Milestone Scientific position as of Q3 2021 after selling out during the quarter.
Tibra Equities Europe sold 163,800 Milestone Scientific shares in Q3 2021, an estimated $401K.
Tibra Equities Europe first reported a position in Milestone Scientific in Q2 2021 and held it in 1 quarter.
Tibra Equities Europe's Milestone Scientific position peaked at $401K in Q2 2021.
37 funds tracked by Wall St. Rank held Milestone Scientific as of Q3 2021.

Based on Tibra Equities Europe's 13F filing for Q3 2021, filed 15 Nov 2021.